Five insights on the hip reconstruction devices market:
1. North America accounted for $2.11 billion of market revenues in 2017 and is expected to hold the leading share in revenue by 2022.
2. The key products in the hip reconstruction devices market are revision, primary cemented, partial hip and primary cementless hip replacement devices, as well as hip resurfacing devices.
3. Demand is higher for primary cemented hip replacement devices and is expected to add $126.6 million in revenues annually from 2017 to 2022.
4. Hospitals, ASCs and orthopedic clinics are the main end users of hip reconstruction devices. Demand among hospitals will increase in the coming years.
5. Major global manufacturers of hip reconstruction devices include United Orthopedic, MicroPort Scientific, Exactech, Zimmer, DePuy Synthes, Smith & Nephew and Stryker.
More articles on orthopedics/TJR:
Top, bottom 5 states for orthopedic surgeon pay
Mississippi outpatient center is 1st to use ROSA robotic device — 3 insights
Surgeon at ASC performs Florida county’s first outpatient hip replacements
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.